Table 2.
Patients | Tumor stage | Grading | Positive lymph nodes | Recurrent disease | Median Follow-up (months) | |||||
---|---|---|---|---|---|---|---|---|---|---|
FIGO I | FIGO II | FIGO III | G1 | G2 | G3 | |||||
Endometrial cancer | 16 | 13 (81%) | 0 | 3 (19%) | 0 | 12 (75%) | 4 (25%) | 4 (25%) | 2 (13%) | 22 (13–28) |
Cervical cancer | 19 | 18 (95%) | 1 (5%) | 0 | 2 (11%) | 14 (74%) | 3 (16%) | 5 (26%) | 1 (5%) | 20 (12–28) |